FDA approves first companion diagnostic to detect gene mutation associated with a type of lung cancer

The U.S. Food and Drug Administration today approved the cobas EGFR Mutation Test, a companion diagnostic for the cancer drug Tarceva .

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352230.htm